Alberta Investment Management Corp Takes $15.29 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Alberta Investment Management Corp acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, Holdings Channel reports. The firm acquired 29,295 shares of the medical equipment provider’s stock, valued at approximately $15,291,000.

Other hedge funds have also recently bought and sold shares of the company. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $26,000. Godsey & Gibb Inc. increased its stake in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the 3rd quarter valued at approximately $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 0.9 %

Shares of Intuitive Surgical stock opened at $601.17 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market capitalization of $214.12 billion, a P/E ratio of 93.79, a PEG ratio of 5.74 and a beta of 1.39. The business’s fifty day moving average price is $561.88 and its 200 day moving average price is $522.27.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 over the last quarter. 0.80% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ISRG. BTIG Research raised their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Evercore ISI raised their price target on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Finally, Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.